Hyun-suk Kim

Ulsan, Republic of Korea

Last Updated: 09/26/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 11 publications

MiR223-3p promotes synthetic lethality in BRCA1-deficient cancers.

Showing 1-11 of 11

Last Updated: 09/26/2026